Bediaga N - Search Results

1

Validation in the general population of a C-peptide estimate equation to measure beta cell function in recent-onset type 1 diabetes.

Wang J, Bediaga N, Mallone R, Larger E, Harrison LC, Wentworth JM; ImMaDiab Study Group. Wang J, et al. Among authors: bediaga n. Acta Diabetol. 2021 Jan;58(1):115-117. doi: 10.1007/s00592-020-01604-7. Epub 2020 Sep 17. Acta Diabetol. 2021. PMID: 32940799 No abstract available.

2

Genome-wide analysis reveals no evidence of trans chromosomal regulation of mammalian immune development.

Johanson TM, Coughlan HD, Lun ATL, Bediaga NG, Naselli G, Garnham AL, Harrison LC, Smyth GK, Allan RS. Johanson TM, et al. PLoS Genet. 2018 Jun 8;14(6):e1007431. doi: 10.1371/journal.pgen.1007431. eCollection 2018 Jun. PLoS Genet. 2018. PMID: 29883495 Free PMC article.

3

Beta cell function in type 1 diabetes determined from clinical and fasting biochemical variables.

Wentworth JM, Bediaga NG, Giles LC, Ehlers M, Gitelman SE, Geyer S, Evans-Molina C, Harrison LC; Type 1 Diabetes TrialNet Study Group; Immune Tolerance Network Study Group. Wentworth JM, et al. Diabetologia. 2019 Jan;62(1):33-40. doi: 10.1007/s00125-018-4722-z. Epub 2018 Aug 30. Diabetologia. 2019. PMID: 30167735 Free PMC article. Review.

4

Minimal variation of the plasma lipidome after delayed processing of neonatal cord blood.

Wentworth JM, Bediaga NG, Penno MAS, Bandala-Sanchez E, Kanojia KN, Kouremenos KA, Couper JJ, Harrison LC; ENDIA Study Group. Wentworth JM, et al. Among authors: bediaga ng. Metabolomics. 2018 Sep 25;14(10):130. doi: 10.1007/s11306-018-1434-9. Metabolomics. 2018. PMID: 30830461

5

Clinical trial data validate the C-peptide estimate model in type 1 diabetes.

Wentworth JM, Bediaga NG, Gitelman SE, Evans-Molina C, Gottlieb PA, Colman PG, Haller MJ, Harrison LC. Wentworth JM, et al. Diabetologia. 2020 Apr;63(4):885-886. doi: 10.1007/s00125-020-05088-6. Epub 2020 Jan 26. Diabetologia. 2020. PMID: 31982961 Free PMC article. No abstract available.

6

Siglec-10 expression is up-regulated in activated human CD4⁺ T cells.

Bandala-Sanchez E, Bediaga NG, Naselli G, Neale AM, Harrison LC. Bandala-Sanchez E, et al. Among authors: bediaga ng. Hum Immunol. 2020 Feb-Mar;81(2-3):101-104. doi: 10.1016/j.humimm.2020.01.009. Epub 2020 Feb 9. Hum Immunol. 2020. PMID: 32046870

7

Factors that predict glycaemic response to sodium-glucose linked transporter (SGLT) inhibitors.

Harding AL, Bediaga N, Galligan A, Colman PG, Fourlanos S, Wentworth JM. Harding AL, et al. Among authors: bediaga n. Intern Med J. 2021 Apr;51(4):515-519. doi: 10.1111/imj.14805. Intern Med J. 2021. PMID: 32092242

8

Extreme disruption of heterochromatin is required for accelerated hematopoietic aging.

Keenan CR, Iannarella N, Naselli G, Bediaga NG, Johanson TM, Harrison LC, Allan RS. Keenan CR, et al. Among authors: bediaga ng. Blood. 2020 Jun 4;135(23):2049-2058. doi: 10.1182/blood.2019002990. Blood. 2020. PMID: 32305044 Free article.

9

Correction to: Validation in the general population of a C-peptide estimate equation to measure beta cell function in recent-onset type 1 diabetes.

Wang J, Bediaga N, Mallone R, Larger E, Harrison LC, Wentworth JM; ImMaDiab Study Group. Wang J, et al. Among authors: bediaga n. Acta Diabetol. 2021 Jan;58(1):119. doi: 10.1007/s00592-020-01616-3. Acta Diabetol. 2021. PMID: 33067722 No abstract available.

10

Multi-level remodelling of chromatin underlying activation of human T cells.

Bediaga NG, Coughlan HD, Johanson TM, Garnham AL, Naselli G, Schröder J, Fearnley LG, Bandala-Sanchez E, Allan RS, Smyth GK, Harrison LC. Bediaga NG, et al. Sci Rep. 2021 Jan 12;11(1):528. doi: 10.1038/s41598-020-80165-9. Sci Rep. 2021. PMID: 33436846 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

37 results

Search Page